Phase 1b Ascending Dose Study of PanChol in Healthy Volunteers

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Cholera Vaccination Reaction
Interventions
BIOLOGICAL

PanChol

Panchol is a novel live attenuated oral cholera vaccine. It is the first vaccine created with the variant El Tor background that is predominant in the world today. The vaccine has ten different genetic modifications to minimize reactogenicity but maintain the ability to colonize the intestine.

Trial Locations (1)

10101

CIDRZ Matero clinical reseach site, Lusaka

All Listed Sponsors
lead

Centre for Infectious Disease Research in Zambia

OTHER